Have a personal or library account? Click to login
Antimicrobial Resistance: Causes And Consequences Cover

Antimicrobial Resistance: Causes And Consequences

Open Access
|Oct 2020

References

  1. Arcilla M.S., Penders J. i wsp.: The carriage of multiresistant bacteria after travel (COMBAT) prospective cohort study: methodology and design. BMC Public Health, doi: 10.1186/1471-2458-14-410 (2014)
  2. Bartsch S.M., McKinnell J.A., Mueller L.E., Miller L.G., Gohil S.K., Huang S.S., Lee B.Y.: Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin. Microbiol. Infect. 23, 48.e9-48.e16 (2017)
  3. Bronzwaer S.L., Cars O., Buchholz U., Mölstad S., Goettsch W., Veldhuijzen I.K., Kool J.L., Sprenger M.J., Degener J.E., European Antimicrobial Resistance Surveillance System.: a European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases, 8, 278–82 (2002)
  4. Bürgmann H., Frigon D., H Gaze W., M Manaia C., Pruden A., Singer A.C., F Smets B., Zhang T.: Water and sanitation: an essential battlefront in the war on antimicrobial resistance. FEMS Microbiol. Ecol. doi: 10.1093/femsec/fiy101 (2018)
  5. Cassini A., Monnet D.L. i wsp.: Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect. Dis. 19, 56–66 (2019)
  6. Cross ELA, Tolfree R, Kipping R.: Systematic review of public-targeted communication interventions to improve antibiotic use. J. Antimicrob. Chemother. 72, 975–87 (2017)
  7. Deptuła A., Trejnowska E., Hryniewicz W.: Badanie punktowe zakażeń związanych z opieką zdrowotną i stosowania antybiotyków w szpitalach pracujących w systemie ostrego dyżuru (PPS HAI&AU) w Polsce. Raport z badania prowadzonego w latach 2016–2018. Narodowy Instytut Leków, Warszawa (2019)
  8. Earnshaw S., Mendez A., Monnet D.L., Hicks L., Cruickshank M., Weekes L., Njoo H., Ross S.: Global collaboration to encourage prudent antibiotic use. Lancet Infect. Dis. 13, 1003–4 (2013)
  9. European Commission: Special Eurobarometer 478 on antimicrobial resistance. EC, 2018
  10. European Commission: A European One Health Action Plan against antimicrobial resistance (AMR). EC, 2017
  11. European Centre for Disease Prevention and Control: Surveillance of antimicrobial resistance in Europe 2018. ECDC, Stockholm, 2019
  12. European Centre for Disease Prevention and Control: Antimicrobial consumption in the EU/EEA, annual epidemiological report for 2018. ECDC, Stockholm, 2019
  13. Frost I., Van Boeckel TP., Pires J., Craig J., Laxminarayan R.: Global geographic trends in antimicrobial resistance: the role of international travel. J. Travel Med. doi: 10.1093/jtm/taz036 (2019)
  14. Gawryszewska I, Żabicka D, Hryniewicz W, Sadowy E.: Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance. Eur. J. Clin. Microbiol. Infect. Dis. 36, 1279–1286 (2017)
  15. Ghafur A.: Antibiotics resistance: taking the road not yet taken. The Hindu (2019) https://www.thehindu.com/sci-tech/health/antibiotics-resistance-taking-the-road-not-yet-taken/article29566793.ece (03.05.2020)
  16. Grigoryan L., Burgerhof J.G., Degener J.E., Deschepper R., Lundborg C.S., Monnet D.L., Scicluna E.A., Birkin J., Haaijer-Ruskamp F.M., SAR consortium.: Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study. Pharmacoepidemiol. Drug Saf. 16, 1234–43 (2007)
  17. Klein E.Y., Van Boeckel T.P., Martinez E.M., Pant S., Gandra S., Levin S.A., Goossens H., Laxminarayan R.: Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc. Natl. Acad. Sci. USA, 115, e3463–e3470 (2018)
  18. Laxminarayan R, Cars O. i wsp.: Antibiotic resistance – the need for global solutions. Lancet Infect. Dis. 13, 1057–98 (2013)
  19. Machowska A., Stalsby Lundborg C.: Drivers of irrational use of antibiotics in Europe. Int. J. Environ. Res. Public. Health, doi: 10.3390/ijerph16010027 (2018)
  20. Magiorakos A.P., Monnet D.L. i wsp.: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268–81 (2012)
  21. Mazińska B, Hryniewicz W.: Polish physicians’ attitudes towards antibiotic prescription and antimicrobial resistance. Pol. J. Microbiol. 66, 309–319 (2017)
  22. Mazińska B, Strużycka I, Hryniewicz W.: Surveys of public knowledge and attitudes with regard to antibiotics in Poland: did the European Antibiotic Awareness Day campaigns change attitudes? PLoS One, 12, e0172146 (2017)
  23. Mölstad S., Cars O. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull. World Health Organ. 95, 764–773 (2017)
  24. Morgan D.J., Okeke I.N., Laxminarayan R., Perencevich E.N., Weisenberg S.: Nonprescription antimicrobial use worldwide: a systematic review. Lancet Infect. Dis. 11, 692–701 (2011)
  25. Newitt S., Oloyede O., Puleston R., Hopkins S., Ashiru-Oredope D.: Demographic, knowledge and impact analysis of 57,627 Antibiotic Guardians who have pledged to contribute to tackling antimicrobial resistance. Antibiotics, 8, e21 (2019)
  26. OECD: Stemming the Superbug Tide. Just a few dollars more. OECD, 2018 https://www.oecd.org/health/stemming-the-super-bug-tide-9789264307599-en.htm
  27. Olczak-Pieńkowska A., Skoczyńska A., Hryniewicz W.: Monthly trends in antimicrobial consumption and influenza incidence at the community level in 2014 in Poland. Pol. Arch. Intern. Med. 128, 731–738 (2018)
  28. O’Neill J.: Tackling drug-resistant infections globally: final report and recommendations. Wellcome Trust, HM Government, 2016
  29. Prestinaci F., Pezzotti P., Pantosti A.: Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health, 109, 309–18 (2015)
  30. Robinson TP., Woolhouse ME. i wsp. Antibiotic resistance is the quintessential One Health issue. Trans. R Soc. Trop. Med. Hyg. 110, 377–80 (2016)
  31. Struzycka I., Hryniewicz W. i wsp.: Knowledge of antibiotics and antimicrobial resistance amongst final year dental students of Polish medical schools-A cross-sectional study. Eur. J. Dent. Educ. 23, 295–303 (2019)
  32. Suetens C., Monnet D.L.: The Healthcare-Associated Infections Prevalence Study Group. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro. Surveill. doi: 10.2807/1560-7917.ES.2018.23.46.1800516 (2018)
  33. Taylor J., Hafner M., Yerushalmi E., Smith R., Bellasio J., Vardavas R., Bienkowska-Gibbs T., Rubin T.: Estimating the economic costs of antimicrobial resistance: model and results. The Wellcome Trust, 2014 https://www.rand.org/pubs/research_reports/RR911.html.
  34. Tyrstrup M., Melander E., Hedin K., Beckman A., Mölstad S.: Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption. BMC Infect. Dis. doi: 10.1186/s12879-017-2703-3 (2017)
  35. United Nations. Political Declaration of the high-level meeting of the General Assembly on antimicrobial resistance. New York, USA, 2016
  36. Ventola C.L.: The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 40, 277–83 (2015)
  37. Woerther P.L., Andremont A., Kantele A.: Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J. Travel Med. 24, S29–S34 (2017)
  38. World Bank: Drug-resistant infections: a threat to our economic future’. World Bank Group, Washington, DC, 2017
  39. World Health Organization: WHO global strategy for containment of antimicrobial resistance. WHO, 2001
  40. World Health Organization: Antimicrobial resistance global report on surveillance. WHO, 2014
  41. World Health Organization: Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. WHO, 2017
  42. World Health Organization: AMR in the WHO European region 2018 http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/about-amr/amr-in-the-who-european-region. (04.05.2020)
  43. World Health Organization: FAO/OIE/WHO Collaboration (Tripartite) https://www.who.int/zoonoses/concept-note/en/ (29.04.2020)
DOI: https://doi.org/10.21307/PM-2020.59.3.18 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 249 - 257
Submitted on: May 1, 2020
Accepted on: Jul 1, 2020
Published on: Oct 12, 2020
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Beata Mazińska, Waleria Hryniewicz, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.